Chandra Williams

506 total citations
10 papers, 374 citations indexed

About

Chandra Williams is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Chandra Williams has authored 10 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Biotechnology. Recurrent topics in Chandra Williams's work include Cancer Research and Treatments (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Chandra Williams is often cited by papers focused on Cancer Research and Treatments (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Chandra Williams collaborates with scholars based in United States, United Kingdom and Singapore. Chandra Williams's co-authors include G.N. Jyothirmayi, Timothy J. Regan, John J. Egan, Peter Ulrich, Michael Brines, Malthi Masurekar, Anthony Cerami, Sara Vasan, Mohammad Asif and Pinku Mukherjee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cells.

In The Last Decade

Chandra Williams

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chandra Williams United States 6 128 125 81 70 68 10 374
Zhong’e Zhou China 4 113 0.9× 58 0.5× 71 0.9× 17 0.2× 300 4.4× 4 541
Nathan A. Trueblood United States 7 39 0.3× 152 1.2× 36 0.4× 30 0.4× 184 2.7× 8 455
Makoto Okabe Japan 13 24 0.2× 176 1.4× 25 0.3× 21 0.3× 145 2.1× 47 389
Munenori Hiromura Japan 13 37 0.3× 91 0.7× 314 3.9× 38 0.5× 175 2.6× 30 505
Debra J. McAndrew United Kingdom 12 25 0.2× 179 1.4× 19 0.2× 18 0.3× 139 2.0× 20 388
Danelle Badenhorst South Africa 11 15 0.1× 335 2.7× 68 0.8× 25 0.4× 146 2.1× 16 493
Naser Safaie Iran 12 16 0.1× 64 0.5× 44 0.5× 19 0.3× 164 2.4× 27 411
Ling Jiang China 9 107 0.8× 18 0.1× 25 0.3× 31 0.4× 275 4.0× 17 406
Young‐Cheol Lim South Korea 8 41 0.3× 19 0.2× 89 1.1× 14 0.2× 154 2.3× 11 416
Seth Truran United States 12 30 0.2× 90 0.7× 114 1.4× 33 0.5× 214 3.1× 23 450

Countries citing papers authored by Chandra Williams

Since Specialization
Citations

This map shows the geographic impact of Chandra Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Williams more than expected).

Fields of papers citing papers by Chandra Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Williams. The network helps show where Chandra Williams may publish in the future.

Co-authorship network of co-authors of Chandra Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Williams. A scholar is included among the top collaborators of Chandra Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Williams. Chandra Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zhou, Ru, Mahboubeh Yazdanifar, Chandra Williams, et al.. (2024). Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host. Journal of Immunotherapy. 47(3). 77–88. 8 indexed citations
2.
Yazdanifar, Mahboubeh, Ru Zhou, Priyanka Grover, et al.. (2019). Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma. Cells. 8(9). 1070–1070. 49 indexed citations
3.
Fowler, Anthony J., Mahboubeh Yazdanifar, Ru Zhou, et al.. (2019). Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. UNC Libraries. 2 indexed citations
4.
Williams, Chandra, et al.. (2018). Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. PLoS ONE. 13(2). e0193260–e0193260. 10 indexed citations
5.
Fowler, Anthony J., Adam B. Fessler, Chandra Williams, et al.. (2018). Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. BMC Cancer. 18(1). 457–457. 26 indexed citations
6.
Hayes, Johnnie R., et al.. (2010). Toxicological evaluation of smokeless tobacco: 90-Day rodent feeding studies. Experimental and Toxicologic Pathology. 64(1-2). 15–24. 11 indexed citations
7.
Hayes, Jeffrey A., Ryan Potts, Paul H. Ayres, et al.. (2010). Toxicological evaluation of smokeless tobacco: 90-Day rodent feeding studies. Toxicology Letters. 196. S229–S229. 1 indexed citations
8.
Williams, Chandra, et al.. (2010). Thermal cycling fatigue analysis of SAC387 solder joints. 1–7. 3 indexed citations
9.
Hayes, Johnnie R., Ryan Potts, Paul H. Ayres, et al.. (2009). Toxicological evaluation of smokeless tobacco: 14- and 28-day feeding studies. Toxicology Letters. 189. S130–S130. 2 indexed citations
10.
Asif, Mohammad, John J. Egan, Sara Vasan, et al.. (2000). An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proceedings of the National Academy of Sciences. 97(6). 2809–2813. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026